viewFrontier IP Group PLC

Frontier IP delighted with first funding round for The Vaccine Group

The fundraising values the University of Plymouth spin-off at £9.5mln, thus giving an assumed value of £1.6mln to Frontier’s 17% stake.

Frontier IP Group PLC -

The Vaccine Group, one of the companies backed by Frontier IP Group PLC (LON:FIPP), has raised £680,000 in its first equity funding round.

The intellectual property commercialisation company said the fundraising values the University of Plymouth spin-off at £9.5mln, thus giving an assumed value of £1.6mln to Frontier’s 17% stake.

The funds raised will be used by The Vaccine Group to accelerate the development and expand the range of its novel animal vaccine technology.

Targeted diseases currently fall into two broad areas: zoonotic diseases, such as Ebola, bird flu and severe acute respiratory syndromes, that jump from animals to animals, including humans; and diseases, such as African swine fever and bovine tuberculosis, which have an impact on economically important livestock.

"Given the much shorter time to market, vaccines designed to interrupt emergence of zoonotic diseases in animals before they spread to humans is becoming regarded as a quicker and more cost-effective way to protect human health," said Michael Jarvis, the founder and chief scientific officer of The Vaccine Group.

Neil Crabb, the chief executive of Frontier IP, said The Vaccine Group’s technology has “huge potential”.

“The World Health Organisation has repeatedly warned about the pandemic threat from zoonotic diseases. Vaccines also have a critical role to play in protecting people from antibiotic-resistant bacteria,” he said.

Quick facts: Frontier IP Group PLC

Price: 54.5 GBX

Market: AIM
Market Cap: £27.62 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...



Frontier IP's The Vaccine Group to begin animal coronavirus vaccine trials...

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's  Andrew Scott its portfolio company The Vaccine Group is to 'imminently' start trials of its coronavirus vaccine in animals. Crabb says the idea is to develop an animal inoculation that would prevent the spread of...

1 week, 6 days ago

2 min read